HEADER HYDROLASE 16-OCT-13 4CBT TITLE DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF POTENT AND SELECTIVE TITLE 2 CLASS IIA HDAC INHIBITORS AS A POTENTIAL THERAPY FOR HUNTINGTON'S TITLE 3 DISEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTONE DEACETYLASE 4; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 648-1033; COMPND 5 SYNONYM: HD4, HDAC4; COMPND 6 EC: 3.5.1.98; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS HYDROLASE, NEURODEGENERATION, HUNTINGTONS DISEASE, AMYOTROPHIC KEYWDS 2 LATERAL SCLEROSIS, MUSCLE ATROPHY, CLASS IIA HISTONE DEACETYLASE KEYWDS 3 INHIBITORS, SAR, HYDROXAMIC ACID, CYCLOPROPANATION EXPDTA X-RAY DIFFRACTION AUTHOR R.W.BURLI,C.A.LUCKHURST,O.AZIZ,K.L.MATTHEWS,D.YATES,K.A.LYONS, AUTHOR 2 M.BECONI,G.MCALLISTER,P.BRECCIA,A.J.STOTT,S.D.PENROSE,M.WALL, AUTHOR 3 M.LAMERS,P.LEONARD,I.MUELLER,C.M.RICHARDSON,R.JARVIS,L.STONES, AUTHOR 4 S.HUGHES,G.WISHART,A.F.HAUGHAN,C.O'CONNELL,T.MEAD,H.MCNEIL,J.VANN, AUTHOR 5 J.MANGETTE,M.MAILLARD,V.BEAUMONT,I.MUNOZ-SANJUAN,C.DOMINGUEZ REVDAT 3 07-FEB-18 4CBT 1 TITLE AUTHOR JRNL REVDAT 2 15-JAN-14 4CBT 1 JRNL REVDAT 1 11-DEC-13 4CBT 0 JRNL AUTH R.W.BURLI,C.A.LUCKHURST,O.AZIZ,K.L.MATTHEWS,D.YATES, JRNL AUTH 2 K.A.LYONS,M.BECONI,G.MCALLISTER,P.BRECCIA,A.J.STOTT, JRNL AUTH 3 S.D.PENROSE,M.WALL,M.LAMERS,P.LEONARD,I.MULLER, JRNL AUTH 4 C.M.RICHARDSON,R.JARVIS,L.STONES,S.HUGHES,G.WISHART, JRNL AUTH 5 A.F.HAUGHAN,C.O'CONNELL,T.MEAD,H.MCNEIL,J.VANN,J.MANGETTE, JRNL AUTH 6 M.MAILLARD,V.BEAUMONT,I.MUNOZ-SANJUAN,C.DOMINGUEZ JRNL TITL DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF POTENT AND JRNL TITL 2 SELECTIVE CLASS IIA HISTONE DEACETYLASE (HDAC) INHIBITORS AS JRNL TITL 3 A POTENTIAL THERAPY FOR HUNTINGTON'S DISEASE. JRNL REF J. MED. CHEM. V. 56 9934 2013 JRNL REFN ISSN 1520-4804 JRNL PMID 24261862 JRNL DOI 10.1021/JM4011884 REMARK 2 REMARK 2 RESOLUTION. 3.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 90.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 19793 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1070 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.03 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.11 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1492 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2520 REMARK 3 BIN FREE R VALUE SET COUNT : 82 REMARK 3 BIN FREE R VALUE : 0.3560 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7899 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 10 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.95000 REMARK 3 B22 (A**2) : 1.95000 REMARK 3 B33 (A**2) : -2.93000 REMARK 3 B12 (A**2) : 0.98000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.536 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.908 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.848 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8192 ; 0.012 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 5404 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11096 ; 1.183 ; 1.960 REMARK 3 BOND ANGLES OTHERS (DEGREES): 13127 ; 4.475 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1036 ; 5.076 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 347 ;36.750 ;23.602 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1242 ;13.742 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 47 ;12.392 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1225 ; 0.260 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 9235 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1695 ; 0.031 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5169 ; 0.192 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2149 ; 0.000 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8247 ; 0.355 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3023 ; 0.311 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2840 ; 0.489 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 4CBT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-OCT-13. REMARK 100 THE DEPOSITION ID IS D_1290058708. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9173 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20882 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.030 REMARK 200 RESOLUTION RANGE LOW (A) : 90.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.16000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.68000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BISTRIS PH 6.5, 22% PEG MME 5000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.96000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 29.48000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 645 REMARK 465 GLY A 646 REMARK 465 SER A 647 REMARK 465 THR A 648 REMARK 465 LYS A 649 REMARK 465 ASN A 729 REMARK 465 ARG A 730 REMARK 465 GLN A 731 REMARK 465 LYS A 732 REMARK 465 LEU A 733 REMARK 465 ASP A 734 REMARK 465 SER A 735 REMARK 465 LYS A 736 REMARK 465 LYS A 737 REMARK 465 LEU A 738 REMARK 465 LEU A 739 REMARK 465 GLY A 740 REMARK 465 SER A 741 REMARK 465 LEU A 742 REMARK 465 ALA A 743 REMARK 465 SER A 744 REMARK 465 VAL A 745 REMARK 465 PHE A 746 REMARK 465 VAL A 747 REMARK 465 ARG A 748 REMARK 465 LEU A 749 REMARK 465 PRO A 750 REMARK 465 CYS A 751 REMARK 465 GLY A 752 REMARK 465 GLY A 753 REMARK 465 VAL A 754 REMARK 465 GLY A 755 REMARK 465 VAL A 756 REMARK 465 ASP A 757 REMARK 465 ASP A 998 REMARK 465 PRO A 999 REMARK 465 LEU A 1000 REMARK 465 PRO A 1001 REMARK 465 GLU A 1002 REMARK 465 LYS A 1003 REMARK 465 VAL A 1004 REMARK 465 HIS A 1035 REMARK 465 HIS A 1036 REMARK 465 HIS A 1037 REMARK 465 HIS A 1038 REMARK 465 HIS A 1039 REMARK 465 MET B 645 REMARK 465 GLY B 646 REMARK 465 SER B 647 REMARK 465 THR B 648 REMARK 465 LEU B 728 REMARK 465 ASN B 729 REMARK 465 ARG B 730 REMARK 465 GLN B 731 REMARK 465 LYS B 732 REMARK 465 LEU B 733 REMARK 465 ASP B 734 REMARK 465 SER B 735 REMARK 465 LYS B 736 REMARK 465 LYS B 737 REMARK 465 LEU B 738 REMARK 465 LEU B 739 REMARK 465 GLY B 740 REMARK 465 SER B 741 REMARK 465 LEU B 742 REMARK 465 ALA B 743 REMARK 465 SER B 744 REMARK 465 VAL B 745 REMARK 465 PHE B 746 REMARK 465 VAL B 747 REMARK 465 ARG B 748 REMARK 465 LEU B 749 REMARK 465 PRO B 750 REMARK 465 CYS B 751 REMARK 465 GLY B 752 REMARK 465 GLY B 753 REMARK 465 VAL B 754 REMARK 465 GLY B 755 REMARK 465 VAL B 756 REMARK 465 ASP B 757 REMARK 465 GLU B 996 REMARK 465 LEU B 997 REMARK 465 ARG B 1034 REMARK 465 HIS B 1035 REMARK 465 HIS B 1036 REMARK 465 HIS B 1037 REMARK 465 HIS B 1038 REMARK 465 HIS B 1039 REMARK 465 HIS B 1040 REMARK 465 MET C 645 REMARK 465 GLY C 670 REMARK 465 SER C 671 REMARK 465 SER C 672 REMARK 465 SER C 673 REMARK 465 ASN C 729 REMARK 465 ARG C 730 REMARK 465 GLN C 731 REMARK 465 LYS C 732 REMARK 465 LEU C 733 REMARK 465 ASP C 734 REMARK 465 SER C 735 REMARK 465 LYS C 736 REMARK 465 LYS C 737 REMARK 465 LEU C 738 REMARK 465 LEU C 739 REMARK 465 GLY C 740 REMARK 465 SER C 741 REMARK 465 LEU C 742 REMARK 465 ALA C 743 REMARK 465 SER C 744 REMARK 465 VAL C 745 REMARK 465 PHE C 746 REMARK 465 VAL C 747 REMARK 465 ARG C 748 REMARK 465 LEU C 749 REMARK 465 PRO C 750 REMARK 465 CYS C 751 REMARK 465 GLY C 752 REMARK 465 GLY C 753 REMARK 465 VAL C 754 REMARK 465 GLY C 755 REMARK 465 VAL C 756 REMARK 465 ASP C 757 REMARK 465 SER C 758 REMARK 465 ASP C 759 REMARK 465 SER C 830 REMARK 465 VAL C 831 REMARK 465 LEU C 997 REMARK 465 ASP C 998 REMARK 465 PRO C 999 REMARK 465 LEU C 1000 REMARK 465 PRO C 1001 REMARK 465 GLU C 1002 REMARK 465 HIS C 1035 REMARK 465 HIS C 1036 REMARK 465 HIS C 1037 REMARK 465 HIS C 1038 REMARK 465 HIS C 1039 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 651 CG CD NE CZ NH1 NH2 REMARK 470 THR A 941 OG1 CG2 REMARK 470 LEU A1005 CG CD1 CD2 REMARK 470 LYS B 649 CG CD CE NZ REMARK 470 ARG B 702 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 958 CG CD CE NZ REMARK 470 LYS B1004 CG CD CE NZ REMARK 470 GLN B1033 CG CD OE1 NE2 REMARK 470 LYS C 649 CG CD CE NZ REMARK 470 ARG C 912 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 996 CG CD OE1 OE2 REMARK 470 LYS C1003 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 681 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG B 681 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG C 681 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 651 88.15 67.68 REMARK 500 PHE A 652 79.42 -67.35 REMARK 500 TRP A 762 102.84 -163.15 REMARK 500 TYR A 814 -60.62 -125.69 REMARK 500 SER A 830 54.27 37.69 REMARK 500 GLU A 879 96.66 -68.71 REMARK 500 LEU A 898 47.07 -100.00 REMARK 500 VAL A 914 -59.69 -122.86 REMARK 500 ALA A 923 68.78 63.44 REMARK 500 GLU A 937 143.92 -39.65 REMARK 500 PRO A 940 162.40 -47.04 REMARK 500 ASN A 947 52.35 -116.48 REMARK 500 GLU A 973 -98.17 -109.94 REMARK 500 PHE B 652 89.22 -62.68 REMARK 500 TRP B 762 97.87 -162.93 REMARK 500 SER B 807 51.09 -154.06 REMARK 500 TYR B 814 -54.24 -132.47 REMARK 500 SER B 830 67.32 60.80 REMARK 500 TYR B 865 -55.99 -133.74 REMARK 500 LEU B 898 47.99 -109.90 REMARK 500 ALA B 923 70.28 57.02 REMARK 500 ASN B 947 52.90 -116.63 REMARK 500 GLU B 973 -99.76 -127.64 REMARK 500 HIS B 976 -48.74 -152.83 REMARK 500 TYR C 658 123.56 -170.54 REMARK 500 ARG C 702 -71.92 -72.80 REMARK 500 GLU C 764 -37.37 -36.95 REMARK 500 VAL C 765 -68.29 -91.78 REMARK 500 ASN C 816 86.69 -67.54 REMARK 500 LYS C 833 116.00 -168.15 REMARK 500 GLU C 879 86.08 -67.84 REMARK 500 ASN C 889 87.01 -163.99 REMARK 500 MET C 892 83.58 -67.96 REMARK 500 ALA C 923 70.22 56.38 REMARK 500 ARG C 967 74.55 -101.90 REMARK 500 GLU C 973 -109.60 -128.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP C 899 PRO C 900 145.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A2036 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 934 OD2 REMARK 620 2 9F4 A2035 O17 88.9 REMARK 620 3 HIS A 842 ND1 112.4 82.5 REMARK 620 4 ASP A 840 OD1 101.2 162.7 106.1 REMARK 620 5 9F4 A2035 O19 119.5 78.5 123.7 84.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A2037 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 669 SG REMARK 620 2 CYS A 667 SG 89.3 REMARK 620 3 HIS A 675 NE2 104.3 100.8 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B2035 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 934 OD2 REMARK 620 2 HIS B 842 ND1 96.4 REMARK 620 3 ASP B 840 OD2 91.8 154.6 REMARK 620 4 9F4 B2034 O19 140.2 116.6 68.2 REMARK 620 5 9F4 B2034 O17 91.0 83.9 120.0 72.3 REMARK 620 6 ASP B 840 OD1 99.2 97.0 57.9 98.2 169.6 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B2036 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 669 SG REMARK 620 2 HIS B 675 NE2 97.6 REMARK 620 3 CYS B 667 SG 89.6 108.2 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN C2036 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP C 934 OD2 REMARK 620 2 ASP C 840 OD2 86.8 REMARK 620 3 ASP C 840 OD1 107.6 56.9 REMARK 620 4 9F4 C2035 O17 85.6 120.5 165.8 REMARK 620 5 HIS C 842 ND1 99.0 158.1 101.4 81.2 REMARK 620 6 9F4 C2035 O19 127.2 63.4 91.8 75.7 125.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN C2037 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS C 675 NE2 REMARK 620 2 CYS C 667 SG 93.0 REMARK 620 3 CYS C 669 SG 164.6 97.1 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9F4 A 2035 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 2036 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 2037 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9F4 B 2034 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 2035 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 2036 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9F4 C 2035 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN C 2036 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN C 2037 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CBY RELATED DB: PDB REMARK 900 DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF POTENT AND REMARK 900 SELECTIVE CLASS IIA HDAC INHIBITORS AS A POTENTIAL THERAPY FOR REMARK 900 HUNTINGTONS DISEASE DBREF 4CBT A 648 1033 UNP P56524 HDAC4_HUMAN 648 1033 DBREF 4CBT B 648 1034 UNP P56524 HDAC4_HUMAN 648 1033 DBREF 4CBT C 648 1033 UNP P56524 HDAC4_HUMAN 648 1033 SEQADV 4CBT MET A 645 UNP P56524 EXPRESSION TAG SEQADV 4CBT GLY A 646 UNP P56524 EXPRESSION TAG SEQADV 4CBT SER A 647 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS A 1034 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS A 1035 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS A 1036 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS A 1037 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS A 1038 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS A 1039 UNP P56524 EXPRESSION TAG SEQADV 4CBT MET B 645 UNP P56524 EXPRESSION TAG SEQADV 4CBT GLY B 646 UNP P56524 EXPRESSION TAG SEQADV 4CBT SER B 647 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS B 1035 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS B 1036 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS B 1037 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS B 1038 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS B 1039 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS B 1040 UNP P56524 EXPRESSION TAG SEQADV 4CBT MET C 645 UNP P56524 EXPRESSION TAG SEQADV 4CBT GLY C 646 UNP P56524 EXPRESSION TAG SEQADV 4CBT SER C 647 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS C 1034 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS C 1035 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS C 1036 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS C 1037 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS C 1038 UNP P56524 EXPRESSION TAG SEQADV 4CBT HIS C 1039 UNP P56524 EXPRESSION TAG SEQRES 1 A 395 MET GLY SER THR LYS PRO ARG PHE THR THR GLY LEU VAL SEQRES 2 A 395 TYR ASP THR LEU MET LEU LYS HIS GLN CYS THR CYS GLY SEQRES 3 A 395 SER SER SER SER HIS PRO GLU HIS ALA GLY ARG ILE GLN SEQRES 4 A 395 SER ILE TRP SER ARG LEU GLN GLU THR GLY LEU ARG GLY SEQRES 5 A 395 LYS CYS GLU CYS ILE ARG GLY ARG LYS ALA THR LEU GLU SEQRES 6 A 395 GLU LEU GLN THR VAL HIS SER GLU ALA HIS THR LEU LEU SEQRES 7 A 395 TYR GLY THR ASN PRO LEU ASN ARG GLN LYS LEU ASP SER SEQRES 8 A 395 LYS LYS LEU LEU GLY SER LEU ALA SER VAL PHE VAL ARG SEQRES 9 A 395 LEU PRO CYS GLY GLY VAL GLY VAL ASP SER ASP THR ILE SEQRES 10 A 395 TRP ASN GLU VAL HIS SER ALA GLY ALA ALA ARG LEU ALA SEQRES 11 A 395 VAL GLY CYS VAL VAL GLU LEU VAL PHE LYS VAL ALA THR SEQRES 12 A 395 GLY GLU LEU LYS ASN GLY PHE ALA VAL VAL ARG PRO PRO SEQRES 13 A 395 GLY HIS HIS ALA GLU GLU SER THR PRO MET GLY PHE CYS SEQRES 14 A 395 TYR PHE ASN SER VAL ALA VAL ALA ALA LYS LEU LEU GLN SEQRES 15 A 395 GLN ARG LEU SER VAL SER LYS ILE LEU ILE VAL ASP TRP SEQRES 16 A 395 ASP VAL HIS HIS GLY ASN GLY THR GLN GLN ALA PHE TYR SEQRES 17 A 395 SER ASP PRO SER VAL LEU TYR MET SER LEU HIS ARG TYR SEQRES 18 A 395 ASP ASP GLY ASN PHE PHE PRO GLY SER GLY ALA PRO ASP SEQRES 19 A 395 GLU VAL GLY THR GLY PRO GLY VAL GLY PHE ASN VAL ASN SEQRES 20 A 395 MET ALA PHE THR GLY GLY LEU ASP PRO PRO MET GLY ASP SEQRES 21 A 395 ALA GLU TYR LEU ALA ALA PHE ARG THR VAL VAL MET PRO SEQRES 22 A 395 ILE ALA SER GLU PHE ALA PRO ASP VAL VAL LEU VAL SER SEQRES 23 A 395 SER GLY PHE ASP ALA VAL GLU GLY HIS PRO THR PRO LEU SEQRES 24 A 395 GLY GLY TYR ASN LEU SER ALA ARG CYS PHE GLY TYR LEU SEQRES 25 A 395 THR LYS GLN LEU MET GLY LEU ALA GLY GLY ARG ILE VAL SEQRES 26 A 395 LEU ALA LEU GLU GLY GLY HIS ASP LEU THR ALA ILE CYS SEQRES 27 A 395 ASP ALA SER GLU ALA CYS VAL SER ALA LEU LEU GLY ASN SEQRES 28 A 395 GLU LEU ASP PRO LEU PRO GLU LYS VAL LEU GLN GLN ARG SEQRES 29 A 395 PRO ASN ALA ASN ALA VAL ARG SER MET GLU LYS VAL MET SEQRES 30 A 395 GLU ILE HIS SER LYS TYR TRP ARG CYS LEU GLN ARG HIS SEQRES 31 A 395 HIS HIS HIS HIS HIS SEQRES 1 B 395 MET GLY SER THR LYS PRO ARG PHE THR THR GLY LEU VAL SEQRES 2 B 395 TYR ASP THR LEU MET LEU LYS HIS GLN CYS THR CYS GLY SEQRES 3 B 395 SER SER SER SER HIS PRO GLU HIS ALA GLY ARG ILE GLN SEQRES 4 B 395 SER ILE TRP SER ARG LEU GLN GLU THR GLY LEU ARG GLY SEQRES 5 B 395 LYS CYS GLU CYS ILE ARG GLY ARG LYS ALA THR LEU GLU SEQRES 6 B 395 GLU LEU GLN THR VAL HIS SER GLU ALA HIS THR LEU LEU SEQRES 7 B 395 TYR GLY THR ASN PRO LEU ASN ARG GLN LYS LEU ASP SER SEQRES 8 B 395 LYS LYS LEU LEU GLY SER LEU ALA SER VAL PHE VAL ARG SEQRES 9 B 395 LEU PRO CYS GLY GLY VAL GLY VAL ASP SER ASP THR ILE SEQRES 10 B 395 TRP ASN GLU VAL HIS SER ALA GLY ALA ALA ARG LEU ALA SEQRES 11 B 395 VAL GLY CYS VAL VAL GLU LEU VAL PHE LYS VAL ALA THR SEQRES 12 B 395 GLY GLU LEU LYS ASN GLY PHE ALA VAL VAL ARG PRO PRO SEQRES 13 B 395 GLY HIS HIS ALA GLU GLU SER THR PRO MET GLY PHE CYS SEQRES 14 B 395 TYR PHE ASN SER VAL ALA VAL ALA ALA LYS LEU LEU GLN SEQRES 15 B 395 GLN ARG LEU SER VAL SER LYS ILE LEU ILE VAL ASP TRP SEQRES 16 B 395 ASP VAL HIS HIS GLY ASN GLY THR GLN GLN ALA PHE TYR SEQRES 17 B 395 SER ASP PRO SER VAL LEU TYR MET SER LEU HIS ARG TYR SEQRES 18 B 395 ASP ASP GLY ASN PHE PHE PRO GLY SER GLY ALA PRO ASP SEQRES 19 B 395 GLU VAL GLY THR GLY PRO GLY VAL GLY PHE ASN VAL ASN SEQRES 20 B 395 MET ALA PHE THR GLY GLY LEU ASP PRO PRO MET GLY ASP SEQRES 21 B 395 ALA GLU TYR LEU ALA ALA PHE ARG THR VAL VAL MET PRO SEQRES 22 B 395 ILE ALA SER GLU PHE ALA PRO ASP VAL VAL LEU VAL SER SEQRES 23 B 395 SER GLY PHE ASP ALA VAL GLU GLY HIS PRO THR PRO LEU SEQRES 24 B 395 GLY GLY TYR ASN LEU SER ALA ARG CYS PHE GLY TYR LEU SEQRES 25 B 395 THR LYS GLN LEU MET GLY LEU ALA GLY GLY ARG ILE VAL SEQRES 26 B 395 LEU ALA LEU GLU GLY GLY HIS ASP LEU THR ALA ILE CYS SEQRES 27 B 395 ASP ALA SER GLU ALA CYS VAL SER ALA LEU LEU GLY ASN SEQRES 28 B 395 GLU LEU ASP PRO LEU PRO GLU LYS VAL LEU GLN GLN ARG SEQRES 29 B 395 PRO ASN ALA ASN ALA VAL ARG SER MET GLU LYS VAL MET SEQRES 30 B 395 GLU ILE HIS SER LYS TYR TRP ARG CYS LEU GLN ARG HIS SEQRES 31 B 395 HIS HIS HIS HIS HIS SEQRES 1 C 395 MET GLY SER THR LYS PRO ARG PHE THR THR GLY LEU VAL SEQRES 2 C 395 TYR ASP THR LEU MET LEU LYS HIS GLN CYS THR CYS GLY SEQRES 3 C 395 SER SER SER SER HIS PRO GLU HIS ALA GLY ARG ILE GLN SEQRES 4 C 395 SER ILE TRP SER ARG LEU GLN GLU THR GLY LEU ARG GLY SEQRES 5 C 395 LYS CYS GLU CYS ILE ARG GLY ARG LYS ALA THR LEU GLU SEQRES 6 C 395 GLU LEU GLN THR VAL HIS SER GLU ALA HIS THR LEU LEU SEQRES 7 C 395 TYR GLY THR ASN PRO LEU ASN ARG GLN LYS LEU ASP SER SEQRES 8 C 395 LYS LYS LEU LEU GLY SER LEU ALA SER VAL PHE VAL ARG SEQRES 9 C 395 LEU PRO CYS GLY GLY VAL GLY VAL ASP SER ASP THR ILE SEQRES 10 C 395 TRP ASN GLU VAL HIS SER ALA GLY ALA ALA ARG LEU ALA SEQRES 11 C 395 VAL GLY CYS VAL VAL GLU LEU VAL PHE LYS VAL ALA THR SEQRES 12 C 395 GLY GLU LEU LYS ASN GLY PHE ALA VAL VAL ARG PRO PRO SEQRES 13 C 395 GLY HIS HIS ALA GLU GLU SER THR PRO MET GLY PHE CYS SEQRES 14 C 395 TYR PHE ASN SER VAL ALA VAL ALA ALA LYS LEU LEU GLN SEQRES 15 C 395 GLN ARG LEU SER VAL SER LYS ILE LEU ILE VAL ASP TRP SEQRES 16 C 395 ASP VAL HIS HIS GLY ASN GLY THR GLN GLN ALA PHE TYR SEQRES 17 C 395 SER ASP PRO SER VAL LEU TYR MET SER LEU HIS ARG TYR SEQRES 18 C 395 ASP ASP GLY ASN PHE PHE PRO GLY SER GLY ALA PRO ASP SEQRES 19 C 395 GLU VAL GLY THR GLY PRO GLY VAL GLY PHE ASN VAL ASN SEQRES 20 C 395 MET ALA PHE THR GLY GLY LEU ASP PRO PRO MET GLY ASP SEQRES 21 C 395 ALA GLU TYR LEU ALA ALA PHE ARG THR VAL VAL MET PRO SEQRES 22 C 395 ILE ALA SER GLU PHE ALA PRO ASP VAL VAL LEU VAL SER SEQRES 23 C 395 SER GLY PHE ASP ALA VAL GLU GLY HIS PRO THR PRO LEU SEQRES 24 C 395 GLY GLY TYR ASN LEU SER ALA ARG CYS PHE GLY TYR LEU SEQRES 25 C 395 THR LYS GLN LEU MET GLY LEU ALA GLY GLY ARG ILE VAL SEQRES 26 C 395 LEU ALA LEU GLU GLY GLY HIS ASP LEU THR ALA ILE CYS SEQRES 27 C 395 ASP ALA SER GLU ALA CYS VAL SER ALA LEU LEU GLY ASN SEQRES 28 C 395 GLU LEU ASP PRO LEU PRO GLU LYS VAL LEU GLN GLN ARG SEQRES 29 C 395 PRO ASN ALA ASN ALA VAL ARG SER MET GLU LYS VAL MET SEQRES 30 C 395 GLU ILE HIS SER LYS TYR TRP ARG CYS LEU GLN ARG HIS SEQRES 31 C 395 HIS HIS HIS HIS HIS HET 9F4 A2035 26 HET ZN A2036 1 HET ZN A2037 1 HET 9F4 B2034 26 HET ZN B2035 1 HET ZN B2036 1 HET 9F4 C2035 26 HET ZN C2036 1 HET ZN C2037 1 HETNAM 9F4 (1R,2R,3R)-2-[4-(5-FLUORANYLPYRIMIDIN-2-YL)PHENYL]-N- HETNAM 2 9F4 OXIDANYL-3-PHENYL-CYCLOPROPANE-1-CARBOXAMIDE HETNAM ZN ZINC ION FORMUL 4 9F4 3(C20 H16 F N3 O2) FORMUL 5 ZN 6(ZN 2+) FORMUL 13 HOH *10(H2 O) HELIX 1 1 ASP A 659 LEU A 663 5 5 HELIX 2 2 ALA A 679 THR A 692 1 14 HELIX 3 3 GLY A 693 CYS A 698 1 6 HELIX 4 4 THR A 707 GLN A 712 1 6 HELIX 5 5 SER A 716 THR A 725 1 10 HELIX 6 6 HIS A 766 THR A 787 1 22 HELIX 7 7 ASN A 816 SER A 830 1 15 HELIX 8 8 GLY A 844 PHE A 851 1 8 HELIX 9 9 ASP A 866 ASN A 869 5 4 HELIX 10 10 THR A 882 VAL A 886 5 5 HELIX 11 11 GLY A 903 VAL A 914 1 12 HELIX 12 12 VAL A 914 ALA A 923 1 10 HELIX 13 13 SER A 949 GLY A 962 1 14 HELIX 14 14 LEU A 963 GLY A 966 5 4 HELIX 15 15 ASP A 977 GLY A 994 1 18 HELIX 16 16 ASN A 1010 SER A 1025 1 16 HELIX 17 17 TRP A 1028 GLN A 1032 5 5 HELIX 18 18 ASP B 659 HIS B 665 5 7 HELIX 19 19 ALA B 679 THR B 692 1 14 HELIX 20 20 GLY B 693 CYS B 698 1 6 HELIX 21 21 THR B 707 GLN B 712 1 6 HELIX 22 22 SER B 716 THR B 725 1 10 HELIX 23 23 HIS B 766 THR B 787 1 22 HELIX 24 24 ASN B 816 SER B 830 1 15 HELIX 25 25 GLY B 844 PHE B 851 1 8 HELIX 26 26 THR B 882 VAL B 886 5 5 HELIX 27 27 GLY B 903 VAL B 914 1 12 HELIX 28 28 VAL B 914 ALA B 923 1 10 HELIX 29 29 ARG B 951 MET B 961 1 11 HELIX 30 30 GLY B 962 GLY B 966 5 5 HELIX 31 31 ASP B 977 GLY B 994 1 18 HELIX 32 32 PRO B 1002 GLN B 1008 1 7 HELIX 33 33 ASN B 1011 SER B 1026 1 16 HELIX 34 34 TRP B 1029 GLN B 1033 5 5 HELIX 35 35 ASP C 659 HIS C 665 5 7 HELIX 36 36 ALA C 679 THR C 692 1 14 HELIX 37 37 GLY C 693 CYS C 698 1 6 HELIX 38 38 THR C 707 GLN C 712 1 6 HELIX 39 39 SER C 716 THR C 725 1 10 HELIX 40 40 HIS C 766 THR C 787 1 22 HELIX 41 41 ASN C 816 ARG C 828 1 13 HELIX 42 42 GLY C 844 PHE C 851 1 8 HELIX 43 43 THR C 882 VAL C 886 5 5 HELIX 44 44 GLY C 903 VAL C 914 1 12 HELIX 45 45 VAL C 914 ALA C 923 1 10 HELIX 46 46 ARG C 951 MET C 961 1 11 HELIX 47 47 GLY C 962 GLY C 966 5 5 HELIX 48 48 ASP C 977 GLY C 994 1 18 HELIX 49 49 LYS C 1003 GLN C 1007 5 5 HELIX 50 50 ASN C 1010 HIS C 1024 1 15 HELIX 51 51 TRP C 1028 GLN C 1032 5 5 SHEET 1 AA 8 GLU A 699 CYS A 700 0 SHEET 2 AA 8 THR A 654 VAL A 657 1 O THR A 654 N GLU A 699 SHEET 3 AA 8 ASN A 792 ALA A 795 1 O ASN A 792 N GLY A 655 SHEET 4 AA 8 ILE A 968 LEU A 972 1 O ILE A 968 N GLY A 793 SHEET 5 AA 8 VAL A 926 SER A 931 1 O VAL A 927 N VAL A 969 SHEET 6 AA 8 ILE A 834 ASP A 838 1 O LEU A 835 N LEU A 928 SHEET 7 AA 8 VAL A 857 ARG A 864 1 O LEU A 858 N ILE A 836 SHEET 8 AA 8 ASN A 889 PHE A 894 1 O VAL A 890 N SER A 861 SHEET 1 BA 8 GLU B 699 ILE B 701 0 SHEET 2 BA 8 GLY B 655 VAL B 657 1 O LEU B 656 N ILE B 701 SHEET 3 BA 8 GLY B 793 ALA B 795 1 O PHE B 794 N VAL B 657 SHEET 4 BA 8 ILE B 968 LEU B 972 1 O ILE B 968 N GLY B 793 SHEET 5 BA 8 VAL B 926 SER B 931 1 O VAL B 927 N VAL B 969 SHEET 6 BA 8 ILE B 834 ASP B 838 1 O LEU B 835 N LEU B 928 SHEET 7 BA 8 VAL B 857 ARG B 864 1 O LEU B 858 N ILE B 836 SHEET 8 BA 8 ASN B 889 PHE B 894 1 O VAL B 890 N SER B 861 SHEET 1 CA 8 GLU C 699 CYS C 700 0 SHEET 2 CA 8 THR C 654 VAL C 657 1 O THR C 654 N GLU C 699 SHEET 3 CA 8 ASN C 792 ALA C 795 1 O ASN C 792 N GLY C 655 SHEET 4 CA 8 ILE C 968 LEU C 972 1 O ILE C 968 N GLY C 793 SHEET 5 CA 8 VAL C 926 SER C 931 1 O VAL C 927 N VAL C 969 SHEET 6 CA 8 ILE C 834 ASP C 838 1 O LEU C 835 N LEU C 928 SHEET 7 CA 8 VAL C 857 ARG C 864 1 O LEU C 858 N ILE C 836 SHEET 8 CA 8 ASN C 889 PHE C 894 1 O VAL C 890 N SER C 861 LINK ZN ZN A2036 OD2 ASP A 934 1555 1555 1.85 LINK ZN ZN A2036 O17 9F4 A2035 1555 1555 2.05 LINK ZN ZN A2036 ND1 HIS A 842 1555 1555 2.14 LINK ZN ZN A2036 OD1 ASP A 840 1555 1555 1.88 LINK ZN ZN A2036 O19 9F4 A2035 1555 1555 2.20 LINK ZN ZN A2037 SG CYS A 669 1555 1555 2.33 LINK ZN ZN A2037 SG CYS A 667 1555 1555 2.34 LINK ZN ZN A2037 NE2 HIS A 675 1555 1555 2.15 LINK ZN ZN B2035 OD2 ASP B 934 1555 1555 1.89 LINK ZN ZN B2035 ND1 HIS B 842 1555 1555 2.12 LINK ZN ZN B2035 OD2 ASP B 840 1555 1555 2.48 LINK ZN ZN B2035 O19 9F4 B2034 1555 1555 2.36 LINK ZN ZN B2035 O17 9F4 B2034 1555 1555 2.00 LINK ZN ZN B2035 OD1 ASP B 840 1555 1555 1.92 LINK ZN ZN B2036 SG CYS B 669 1555 1555 2.33 LINK ZN ZN B2036 NE2 HIS B 675 1555 1555 2.16 LINK ZN ZN B2036 SG CYS B 667 1555 1555 2.33 LINK ZN ZN C2036 OD2 ASP C 934 1555 1555 1.86 LINK ZN ZN C2036 OD2 ASP C 840 1555 1555 2.56 LINK ZN ZN C2036 OD1 ASP C 840 1555 1555 1.92 LINK ZN ZN C2036 O17 9F4 C2035 1555 1555 2.03 LINK ZN ZN C2036 ND1 HIS C 842 1555 1555 2.13 LINK ZN ZN C2036 O19 9F4 C2035 1555 1555 2.28 LINK ZN ZN C2037 NE2 HIS C 675 1555 1555 2.15 LINK ZN ZN C2037 SG CYS C 667 1555 1555 2.51 LINK ZN ZN C2037 SG CYS C 669 1555 1555 2.34 CISPEP 1 ARG A 798 PRO A 799 0 2.73 CISPEP 2 PHE A 871 PRO A 872 0 -6.20 CISPEP 3 ASP A 899 PRO A 900 0 0.23 CISPEP 4 ARG B 702 GLY B 703 0 4.40 CISPEP 5 ARG B 798 PRO B 799 0 1.34 CISPEP 6 PHE B 871 PRO B 872 0 -4.82 CISPEP 7 ASP B 899 PRO B 900 0 -3.51 CISPEP 8 ARG C 798 PRO C 799 0 -0.04 CISPEP 9 PHE C 871 PRO C 872 0 -3.46 CISPEP 10 THR C 941 PRO C 942 0 3.19 SITE 1 AC1 13 ASN A 726 LEU A 728 VAL A 765 HIS A 802 SITE 2 AC1 13 HIS A 803 PHE A 812 ASP A 840 HIS A 842 SITE 3 AC1 13 PHE A 871 ASP A 934 LEU A 943 GLY A 974 SITE 4 AC1 13 ZN A2036 SITE 1 AC2 4 ASP A 840 HIS A 842 ASP A 934 9F4 A2035 SITE 1 AC3 3 CYS A 667 CYS A 669 HIS A 675 SITE 1 AC4 12 ARG B 681 ASN B 726 HIS B 802 HIS B 803 SITE 2 AC4 12 PHE B 812 ASP B 840 HIS B 842 PHE B 871 SITE 3 AC4 12 ASP B 934 PRO B 942 GLY B 975 ZN B2035 SITE 1 AC5 4 ASP B 840 HIS B 842 ASP B 934 9F4 B2034 SITE 1 AC6 3 CYS B 667 CYS B 669 HIS B 675 SITE 1 AC7 12 ARG C 681 ASN C 726 HIS C 802 HIS C 803 SITE 2 AC7 12 GLY C 811 PHE C 812 ASP C 840 HIS C 842 SITE 3 AC7 12 PHE C 871 ASP C 934 GLY C 974 ZN C2036 SITE 1 AC8 4 ASP C 840 HIS C 842 ASP C 934 9F4 C2035 SITE 1 AC9 3 CYS C 667 CYS C 669 HIS C 675 CRYST1 104.410 104.410 88.440 90.00 90.00 120.00 P 32 9 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009578 0.005530 0.000000 0.00000 SCALE2 0.000000 0.011059 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011307 0.00000